Half a decade after Abcam quit its 270 million pound sterling pursuit of Horizon Discovery, the British antibody research expert has potentially found itself on the opposite end of the dealmaking ...

As British research supplies and tools provider Abcam moves toward a potential multibillion-dollar sale, one of the company's founders and major shareholders is pushing back. Dr. Jonathan Milner, an ...

Horizon Discovery has rejected a £270 million ($367 million) takeover bid from Abcam. The gene editing specialist issued a strongly-worded rebuttal of the offer after Abcam went public with its plan, ...

Abcam PLC (NASDAQ:ABCM) is a $3.8 billion market cap biotechnology stock on the Nasdaq Global Select Market. It is moving its primary listing from Londons AIM (previously known as the Alternative ...

Back in June, Abcam’s CEO Alan Hirzel and his predecessor, founder Jonathan Milner, PhD, resolved a bitter battle over the company’s direction by agreeing to explore strategic alternatives. One of ...

For more than a decade, Abcam has been known as the “Amazon of Antibodies” because of its selection of over 110,000 products to research protein targets, from antibodies to proteins, lysates, ...

Activist investor Starboard Value said it supports Abcam's (NASDAQ:ABCM) announcement that it plans to conduct a strategic review, including a potential sale. "We’re pleased that both Abcam and ...

Abcam has ended its pursuit of Horizon Discovery one week after going public about its attempt to buy the gene editing specialist. Cambridge, U.K.-based Abcam painted its proposed £270 million ($367 ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Abcam has defended the handling of its proposed $5.7bn takeover by Danaher, insisting that the UK life sciences ...

Update 6:32pm: Adds Starboard Value comment. Abcam (NASDAQ:ABCM) founder Jonathan Milner said he suspended his proxy solicitation effort after the biotech company said Friday it would evaluate ...

Investing.com -- Diagnostic tool supplier Danaher Corporation (NYSE:DHR) has agreed to acquire medical equipment manufacturer Abcam PLC (NASDAQ:ABCM) in a deal worth $5.7 billion including debt, the ...

Life sciences company Abcam is one of Glassdoor's happiest places to work in the UK. The company is growing and hired around 500 people during the pandemic. One of its top recruiters offered five tips ...